You are here: Industry Insights > Oncology

News List

Oncology development programme launches at UK life science campus pharmatimes
November 06, 2020
A new national oncology development programme is being launched by Bruntwood SciTech at Alderley Park, the UK’s largest single site life science campus.
Crown Biosciences Opens Facility in China contractpharma
November 06, 2020
Crown Bioscience, a JSR Life Sciences company, has opened a new oncology-focused research facility in Zhongshan, China to satisfy increased customer demand.
New Study Finds COVID-19 Substantially Reduced Cancer Screenings, Diagnosis, and Treatments in 2020 prnewswire
October 22, 2020
Breast, colon, prostate, and lung cancers did not stop for COVID-19 in 2020, but screenings and treatments did. Dramatically. The result, say doctors, could be a catastrophe in the making.
Boehringer expands oncology partnership with Oxford BioTherapeutics pharmaceutical-technology
October 16, 2020
Boehringer Ingelheim has announced the expansion of its partnership with UK-based Oxford BioTherapeutics (OBT) to discover novel selective targets for strategic cancer indications to deliver treatments for cancer patients.
Kanaph Therapeutics Closes 21M USD Series B Funding prnasia
October 15, 2020
Kanaph Therapeutics, a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules, recently completed their Series B funding of 21M USD in South Korea.
Antengene, WuXi Biologics Ink Innovative Oncology R&D Alliance contractpharma
October 14, 2020
Partner for the development and production of novel drugs, and to jointly promote R&D of innovative oncology therapies.
Pfizer and CStone to collaborate for oncology therapies in China expresspharma
October 09, 2020
CStone to receive up to $280 million in milestone payments for sugemalimab, and additional royalties.
Bispecific antibodies will mature after 2021, $6bn estimated sales in oncology by 2025: GlobalData expresspharma
October 09, 2020
There are 106 bispecific antibody molecules in the pipeline and 263 ongoing/planning to enrol clinical trials involving a bispecific antibody.
Accenture reveals data science project for paediatric leukaemia pharmatimes
September 30, 2020
Accenture Applied Intelligence announced a new data and analytics approach to manage and derive insights from paediatric acute myeloid leukaemia (AML) genomic data, with the potential to improve precision medicine.
New Guidelines for Maximizing Cures and Minimizing Side Effects in Children with Hodgkin Lymphoma prnasia
September 30, 2020
The National Comprehensive Cancer Network® (NCCN®) announced the publication of new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Pediatric Hodgkin Lymphoma.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page